
View on market: Volatility persists, eagerly searching for growth
US equity futures rose after the S&P 500 and Nasdaq 100 ended at record highs on Thursday. Strong retail sales in June helped ease fears about a slowdown in consumer spending and gave confidence in the strength of the US economy. All major US indices closed higher, with the S&P 500 briefly crossing a key psychological level. In India, markets ended lower on Thursday after two days of gains. Major stocks like Infosys and HDFC Bank dragged the indices down. The Nifty 50 struggled to break through a resistance level due to options trading activity on expiry day. In Asia, stocks opened with small gains on Friday, following the global rally. Investors were encouraged by solid US economic data, which helped reduce worries about a slowdown and boosted overall market sentiment. The broader mood in markets is positive, with hopes that the strong data will support continued growth.
Key Quarterly Results for Today:
3IINFOLTD, AAPLUSTRAD, AARTIDRUGS, ALKALI, ARCEEIN, BANDHANBNK, HINDZINC, ICL, INDBANK, INDIAMART, IOB, JAYNECOIND, JSWSTEEL, LTF, MASTEK, RELIANCE, ROSELABS, TECHKGREEN, WAAREEINDO.
Economic Calendar:
- USD: Initial and Continuing Jobless Claims Data on 24th July 2025.
- IND: Bank Loan and Deposit Growth Rate on 18th July 2025.
- USD: S&P Global Manufacturing PMI (July) on 24th July 2025.
- IND: Foreign Reserves USD on 18th July 2025.
IPO Watch:
Company | Open | Close | Price | View |
NA |
Brokerage Radar:
MACQUARIE ON TATA COMMUNICATIONS:
Maintain Outperform with TP of Rs 2300, Mild Q1 miss: Digital Portfolio growing; Others soft, Find quarterly calibration for multi-segment B2B businesses challenging, Q1 results on its own present mild downside to our forecast, Still see clear revenue-side growth levers to drive 300 bps EBITDA margin expansion.
JEFFERIES ON INDIAN HOTELS:
Maintain Buy; Cut TP to Rs 960 from Rs 980, Decent performance in turbulent quarter Mgmt maintained double digit rev growth guidance for FY26 and healthy Q2, IHCL is adding rooms at ~12% CAGR over next 5 years, with several greenfield assets also contributing to growth.
MORGAN STANLEY ON HDFC AMC:
Maintain Equal-weight; Hike TP to Rs 4910 from Rs 4470, Q1: good quarter, Operating profit was in-line, though revenue yields were better, HDFC AMC benefits from its FY25 commission rationalization efforts, Find valuation expensive from a longer-term perspective.
MACQUARIE ON AXIS BANK:
Maintain Outperform with TP of Rs 1450, Q1 results: PAT miss driven by higher credit costs, High credit costs concerning, partially affected by policy change, Growth aspirations onerous; downside risks persist for our ROA estimates.
International Markets:
U.S & Europe:
Particulars | 17th July | Chg. | Chg.(%) |
Nasdaq | 20,884.27 | 153.78 | 0.74 |
Dow | 44,484.49 | 229.71 | 0.52 |
FTSE | 8,972.64 | 46.09 | 0.51 |
CAC | 7,822.00 | 99.91 | 1.28 |
DAX | 24,370.93 | 286.89 | 1.16 |
Dow Fut.* | 44,596.01 | 111.52 | 0.25 |
*As per 18th July.
Asian markets:
Particulars | 18th July | Chg. | Chg.(%) |
GIFT Nifty | 25,189.50 | 14.90 | 0.06 |
Nikkei | 39,778.85 | -122.34 | -0.31 |
Straits Times | 4,179.97 | 18.54 | 0.45 |
Hang Seng | 24,745.76 | 246.81 | 1.01 |
Shanghai | 3,530.15 | 13.32 | 0.38 |
Stocks strong on Chart:
Index | F&O | Cash |
RELIANCE | IRFC | RALLIS INDIA |
JIOFIN | PNB | CEAT |
BEL | INOXWIND | BEML |
NTPC | ASHOKLEY | MAX ESTATE |
ITC | PFC | NIPPON AMC |
HDFC BANK | RECLTD | MINDACORP |
Commodities & Currency:
Particulars | Current Price | Chg.(%) |
USD/INR | 85.983 | -0.04 |
Brent | 69.47 | -0.07 |
Gold | 97,480 | 0.01 |
Silver | 112,408 | 0.07 |
FIIs & DIIs:
Particulars | 17th July | 16th July |
FIIs | -3,694.31 | -1,858.15 |
DIIs | 2,820.77 | 1,223.55 |
News Updates:
Afcons Infra: |
Emerged as lowest bidder in two road construction contracts worth Rs 4,535 crore from Croatian Motorways. |
EMS: | Has received an order worth Rs 19.46 crore for electrical works from Deltabulk Shipping India. |
Mahindra & Mahindra: | The company’s arm, Mahindra Logistics, received approval for a rights issue of shares valued at RS 749 crore, with an issue price set at Rs 277 per share. |
Sun Pharma: | Has incorporated arm Sun Pharma (Hainan) in China. |
Source: Moneycontrol, Bloomberg Quint, Investing
Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 214
Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India. (SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Vindhyachal Prasad, Elite Wealth Limited, vindhyachal@elitestock.com
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
- all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
- No part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or emailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale. Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone: 011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in
EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
- Reports
- a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
- EWL or its associates or relatives, have no actual/beneficial ownership of one %. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
- EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
-
- Compensation
-
- EWL or its associates have not received any compensation from the subject company in the past twelve months;
- EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
- EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
- EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
- EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research
- In respect of Public Appearances
- EWL or its associates have not received any compensation from the subject company in the past twelve months;
- The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL